Fcε receptor II/CD23+ lymphocytes in atopic dermatitis. III. Aberrant control in the in vitro expression of FcεRII/CD23 on peripheral blood T cells in atopic dermatitis - SAKAMOTO, T.; NAKAYAMA, F.; TAMAMORI, T.; TAKIGAWA, M. (Clinical and experimental immunology, 1992)
Keywords: Adolescent; Adult; Aged; Antigens, Differentiation, B-Lymphocyte - analysis; atopic dermatitis; Biological and medical sciences; cells; Dermatitis, Atopic - immunology; Dermatology; Dinoprostone - pharmacology; FcεRII IL‐4; Female; Humans; in vitro culture; Interferon Type I - pharmacology; Interferon-gamma - pharmacology; Interleukin-2 - pharmacology; Interleukin-4 - pharmacology; Male; Medical sciences; Middle Aged; Phytohemagglutinins; Receptors, Fc - analysis; Receptors, IgE; Recombinant Proteins - pharmacology; Skin involvement in other diseases. Miscellaneous. General aspects; T-Lymphocyte Subsets - immunology; T-Lymphocytes - immunology; Human; Immunopathology; Skin disease; Regulation(control); Fc-Fragment; Atopic dermatitis; T-Lymphocyte; Biosynthesis; Cell subpopulation; Cell surface; Biological receptor